Barrow, Timothy M.
Nakjang, Sirintra
Lafta, Fadhel
Bilotkach, Kateryna
Woodhouse, Laura
Junge, Gesa
Tudhope, Susan J.
Wallis, Jonathan P.
Marr, Helen
Marshall, Scott
Bown, Nick
Willmore, Elaine
Strathdee, Gordon
Funding for this research was provided by:
Bloodwise (14024, 14024)
JGW Patterson Foundation (30015.088.045/PA/IXS)
Article History
Received: 10 May 2020
Revised: 16 September 2020
Accepted: 25 September 2020
First Online: 21 October 2020
Ethics approval and consent to participate
: Ethical approval for this study was granted by the North East—Newcastle & North Tyneside 1 Research Ethics Committee (REC reference number 17/NE/0361, ExternalRef removed). All donors provided written informed consent. The study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The Illumina Infinium HumanMethylation450 BeadChip microarray datasets from 24 patients at two timepoints during the course of treatment are available in the Gene Expression Omnibus repository (ExternalRef removed).
: The authors declare no competing interests.
: This work was supported by funding from Bloodwise (grant number 14024, to Gordon Strathdee and Elaine Willmore) and the JGW Patterson foundation (grant number 30015.088.045/PA/IXS, awarded to Gordon Strathdee).